Disclaimer

The information contained is not intended for publication, use or distribution to or by any person from any other country. In particular, this information is not intended for distribution in the United States of America (USA), for citizens of the USA or for persons resident or domiciled in the USA or persons acting on their behalf. The content provided is for information purposes only. In particular, it does not constitute an offer to sell, buy or subscribe to securities or other instruments. Insofar as persons resident or domiciled abroad access the information contained on the website, the operator of the website does not give any assurance or guarantee that the information contained complies with the provisions applicable in the country concerned. All information on this website is intended exclusively for persons domiciled or habitually resident in Germany. Furthermore, I confirm that I am a professional investor within the meaning of Section 67 II of the German Securities Trading Act (WpHG). I am aware that I enjoy a reduced level of protection compared to a private client with regard to financial services. This website uses cookies to improve the user experience. By using this website, you agree to the use of cookies by our website.I confirm that I meet the above requirements with regard to the investor group and have read, understood and accepted the information regarding the use and distribution restrictions. The investment advice pursuant to Section 2 (2) No. 4 of the German Securities Trading Act (WpIG) and the investment brokerage pursuant to Section 2 (2) No. 3 of the German Securities Trading Act (WpIG) are provided on behalf of, in the name of, for the account of and under the liability of the liable party BN & Partners Capital AG, Steinstraße 33, 50374 Erftstadt, pursuant to Section 3 (2) WpIG. BN & Partners Capital AG has been granted a corresponding license for the aforementioned financial services by the German Federal Financial Supervisory Authority (BaFin) pursuant to Section 15 WpIG.

Welcome to Ultramarin

We are Building the Future of Capital Investment

Our Specialization

We develop AI-based forecasting models for global equity markets, empowering investors to make better investment decisions.

Our Solutions

You can benefit from our AI-based stock forecasts in various ways.

Investment Funds & Individual Mandates

Our investment funds give you direct access to AI-based equity strategies. Customized solutions can be implemented through Individual mandates.

100 % systematic and transparent:

No irrational or discretionary decisions

Holistic:
Millions of data points are processed and analyzed every trading day

Adaptive design:

AI models constantly learn and adapt to structural changes

Three white circles in the Ultramarin Design.

Index Solutions

You can participate in the performance of AI-optimized stock indices via ETFs.

100 % systematic:

Quantitatively powered optimization of the index

Sustainable:
ESG-compliant diversified equity investment

Index proximity:
Low tracking error to major market indices

Three white circles in the Ultramarin Design.

Ultrascope

Ultrascope gives you access to AI-based equity research on more than 5,000 companies worldwide.

Globale coverage:

A more comprehensive scope and deeper insights than human analyst teams

On Demand:
Available 24/7

Flexibility:

Easy integration into different use cases via modern API

Three white circles in the Ultramarin Design.

Symbiotic Conception

We combine the potential of Artificial Intelligence with best practices in quantitative asset management.

Modern aquarelle painting in the Ultramarin design using the colors light blue, black and yellow.

Driven by Performance

Where others see only white noise in financial markets, for us, the fascination starts. We are committed to shaping the era of AI in capital investment.

Ultrascope Snapshot

Screenshot of Ultrascope with detailed financial metrics analysis and predictions for the Apple stock.

Are you interested in learning more?

Get your personal login details.